SEC Form 4 · accession 0001192482-16-000733
INTERPACE BIOSCIENCES, INC. · IDXG
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jack E Stover
Officer — President and CEO · Director
Period of report
Oct 14, 2016
Accepted (ET)
Oct 18, 2016 · 4:25 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001054102
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | holding | — | — | — | 197,378 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $0.16 | Oct 14, 2016 | A | 326,368 | A | — | Oct 14, 2026 | Common Stock | 326,368 | 326,368 | D |
Explanation of responses
- F1The options will vest in equal monthly installments over a period of one year.